- Home
- Labeler Index
- Antares Pharma, Inc.
- 18657-117
- NDC Crossover: 18657-117 Hylenex Recombinant
NDC Crossover 18657-117 Hylenex Recombinant
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Hyaluronidase (human Recombinant)
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 18657-117 – Hylenex Recombinant, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Hylenex Recombinant
- OR Generic name: Hyaluronidase
- AND the same Administration Route: subcutaneous
- OR Dosage Form: injection, solution
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
50090-4534 | Hylenex Recombinant | Hyaluronidase (human Recombinant) | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
51662-1555 | Hyaluronidase | Hyaluronidase | Injection, Solution | Subcutaneous | Hf Acquisition Co Llc, Dba Healthfirst | Human Prescription Drug |